Cargando…

Serum osteoprotegerin and renal function in the general population: the Tromsø Study

BACKGROUND: Serum osteoprotegerin (OPG) is elevated in patients with chronic kidney disease (CKD) and increases with decreasing renal function. However, there are limited data regarding the association between OPG and renal function in the general population. The aim of the present study was to expl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vik, Anders, Brodin, Ellen E., Mathiesen, Ellisiv B., Brox, Jan, Jørgensen, Lone, Njølstad, Inger, Brækkan, Sigrid K., Hansen, John-Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Biomarkers in CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469572/ https://www.ncbi.nlm.nih.gov/pubmed/28638603 http://dx.doi.org/10.1093/ckj/sfw095

Ejemplares similares

Serum osteoprotegerin levels are related to height loss: The Tromsø Study
por: Jørgensen, Lone, et al.
Publicado: (2011)

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
por: Skjelbakken, Tove, et al.
Publicado: (2014)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study
por: Solomon, Terry, et al.
Publicado: (2016)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
por: Johnsen, Stein Harald, et al.
Publicado: (2018)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Cohort profile: The Tromsø Study
por: Jacobsen, Bjarne K, et al.
Publicado: (2012)

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study
por: Lappegård, Jostein, et al.
Publicado: (2018)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

Association of occasional smoking with total mortality in the population-based Tromsø study, 2001–2015
por: Løchen, Maja-Lisa, et al.
Publicado: (2017)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2015)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2020)

Data from national health registers as endpoints for the Tromsø Study: Correctness and completeness of stroke diagnoses
por: Varmdal, Torunn, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Atrial Fibrillation and Cause‐Specific Risks of Pulmonary Embolism and Ischemic Stroke
por: Hald, Erin M., et al.
Publicado: (2018)

Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012
por: Carlsson, Maria, et al.
Publicado: (2016)

Sex-Specific Associations between Blood Pressure and Risk of Atrial Fibrillation Subtypes in the Tromsø Study
por: Espnes, Hilde, et al.
Publicado: (2021)

Macular thickness in healthy eyes of adults (N = 4508) and relation to sex, age and refraction: the Tromsø Eye Study (2007–2008)
por: von Hanno, Therese, et al.
Publicado: (2016)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

Renal artery intervention utilizing carbon dioxide angiography
por: Sag, Alan A, et al.
Publicado: (2017)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Current trends in European renal epidemiology
por: Heaf, James
Publicado: (2017)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8d9ub0ufem7rr4hug0gmf8a45m